Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ IL-17/IL-17A Antibody Blocking Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP176337PEP
Description
A blocking peptide containing 19 amino acids near the center of human IL-17. Source: Synthetic (Accession #: NP_002181) The IL-17/IL-17A Blocking Peptide has been validated for the following applications: Antibody Competition.Specifications
| 3605 | |
| Store at -20 C. Avoid freeze-thaw cycles. | |
| This Peptide is Useful as a Blocking Peptide for NBP1-76337. For Further Blocking Peptide Related Protocol, Click Here . | |
| IL17A | |
| 0.05 mg | |
| Synthetic |
| Human | |
| PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. | |
| CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, IL-17 Acytotoxic T-lymphocyte-associated protein 8, IL-17 CTLA-8, IL17interleukin-17 A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17 A | |
| IL-17/IL-17A | |
| RUO - research use only | |
| 19 amino acids near the center of human IL-17 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction